Rubius Therapeutics, Inc. (RUBY) Stock Price & Growth Analysis

Quote Panel

Updated October 3, 2024

1W % 1M % 3M % 1Y 251.85 %

Key Metrics

Market Cap
7.51M
Shares Outstanding
90.48M
Share in Float
85.39M
Dividende
0

Earning Date
No Data
Price Target
0.083
Average Volume
99535
Beta
2.208

Range
0.0032-0.3763
Industry
Biotechnology
Website
https://www.rubiustx.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

0.50x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-2.0

EPS

How RUBY compares to sector?

P/E Ratio

Relative Strength

RUBY

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$0.34

26%

2022-EPS

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Guggenheim

downgrade

Previous: Not converted

2022-09-13

Now: Neutral

Earnings Growth

YoY

Current

Estimates

Q1.21

N/A

-0.51
vs -0.60

Q2.21

N/A

-0.56
vs -0.47

Q3.21

N/A

-0.55
vs -0.51

Q4.21

N/A

-0.61
vs -0.50

Q1.22

N/A

-0.58
vs -0.51

Q2.22

N/A

-0.49
vs -0.56

Q3.22

N/A

-0.37
vs -0.55

Q4.22

N/A

-0.61
vs -0.61

Q1.23

+346%

1.43
vs -0.58

Q2.23

N/A

-0.34
vs -0.49

Sales Growth

YoY

Current

Estimates

Q3.20

NA vs NA

Q4.20

NA vs NA

Q1.21

NA vs NA

Q2.21

NA vs NA

Q3.21

NA vs NA

Q4.21

NA vs NA

Q1.22

NA vs NA

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Return on Equity

QoQ

Q1.21

-14%

-0.14
vs -0.29

Q2.21

-19%

-0.19
vs -0.14

Q3.21

-22%

-0.22
vs -0.19

Q4.21

-31%

-0.31
vs -0.22

Q1.22

-40%

-0.40
vs -0.31

Q2.22

-48%

-0.48
vs -0.40

Q3.22

-254%

-2.54
vs -0.48

Q4.22

-273%

-2.73
vs -2.54

Institutionnal Ownership

QoQ

Q2.21

114

114
vs 114

Q3.21

111

111
vs 114

-3%

Q4.21

110

110
vs 111

-1%

Q1.22

123

123
vs 110

12%

Q2.22

69
vs 123

-44%

Q3.22

57
vs 69

-17%

Q4.22

40
vs 57

-30%

Q1.23

5
vs 40

-87%

Company Description

N/A

0.00x

0.50x

0.1

0.0%

$-2.0

$0.34

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!